AGP Picks
View all

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 13, 2026

PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Seer Files Patent Infringement Lawsuit Against Nanomics
Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
Andera Partners Leads $20 Million Series D Financing in Rivermark Medical

Share this page:

Sign up for:

Florida Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.